All Episodes
Pharma and BioTech Daily — 105 episodes
Replimune's RP1 Resubmission to FDA: Will It Finally Pass? | Pharma and Biotech Daily
Merck's $11.3B Bio-Techne Acquisition | Pharma and Biotech Daily
Eli Lilly's $1.9B Abbisko Partnership Boosts Cancer R&D | Pharma and Biotech Daily
Carsgen's $2T Satricabtagene Approval Milestone | Pharma and Biotech Daily
Carsgen's CAR-T Breakthrough in China for Solid Tumors | Pharma and Biotech Daily
FDA Approves Alzheimer's Drug Amid Debate | Pharma and Biotech Daily
FDA Approves Utebzi, Biogen Acquires Raythera for $1B | Pharma and Biotech Daily
Eli Lilly's $65B M&A Surge & FDA's Drug Import Approval | Pharma and Biotech Daily
Intellia's 89% Success in Phase 3 CRISPR Trial | Pharma and Biotech Daily
Novartis' $23M RNA Breakthrough & Tavneos FDA Battle | Pharma and Biotech Daily
Takeda's Zasocitinib Beats Sotyktu in Phase 3 Trial | Pharma and Biotech Daily
Pfizer CEO Rethinks Germany Investments Amid Reform Concerns | Pharma and Biotech Daily
Merck & Gilead's HIV Pill Breakthrough: Phase 3 Success! | Pharma and Biotech Daily
Eli Lilly's Retatrutide Breakthrough: 30.3% Weight Loss Success | Pharma and Biotech Daily
Pfizer & Chai AI Breakthrough: $1.675B Gilead Deal | Pharma and Biotech Daily
Eli Lilly & Boehringer Cut $1B+ Investments in Germany | Pharma and Biotech Daily
Legend Biotech's CAR T-Cell Breakthrough: 100% Response Rate | Pharma and Biotech Daily
Moderna-Merck Combo Cuts Melanoma Risk by 49% | Pharma and Biotech Daily
Akeso's Ivonescimab Shows 34% Death Risk Cut at ASCO | Pharma and Biotech Daily
Pfizer's $10B Innovent Deal Boosts Cancer Drugs | Pharma and Biotech Daily
Eli Lilly's Zepbound Coverage Restored! Breaking News | Pharma and Biotech Daily
Outlook Therapeutics Wins FDA Appeal for $1.3B Deal | Pharma and Biotech Daily
Gilead's Hepcludex FDA Approval Marks Milestone | Pharma and Biotech Daily
Lilly's Obesity Drug Rivals Surgery: FDA Changes Ahead | Pharma and Biotech Daily
AstraZeneca's Datroway FDA Approved for TNBC | Pharma and Biotech Daily
Eli Lilly's $1B Novo Nordisk Deal: Diabetes Focus | Pharma and Biotech Daily
Pfizer Leads Pneumococcal Vaccine Efforts | Pharma and Biotech Daily
Takeda Faces $885M Verdict in Antitrust Case | Pharma and Biotech Daily
Regeneron $2.3B Deal & FDA Shake-Up | Pharma and Biotech Daily
Eisai's Leqembi Forecasts $900M Sales Boost | Pharma and Biotech Daily
Beone's Beqalzi FDA Approval Challenges AbbVie | Pharma and Biotech Daily
Takeda Lays Off 4,500 | FDA Leadership Change News | Pharma and Biotech Daily
Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily
Daiichi Sankyo's $1.3B Oncology Plan & CSL's $5B Setback | Pharma and Biotech Daily
Gilead Projects $1B YezTugo Sales | Pharma and Biotech Daily
Roche Acquires PathAI for $1B: AI-Driven Diagnostics Revolution | Pharma and Biotech Daily
Bayer's $2.4B Perfuse Deal Shakes Up Eye Care | Pharma and Biotech Daily
Sanofi Invests $294M in AI, FDA Approves Auvelity | Pharma and Biotech Daily
Pfizer's $300M Biologics Boost & FDA's Veppanu Approval | Pharma and Biotech Daily
AstraZeneca's $5B Setback: FDA Rejects New Cancer Drug | Pharma and Biotech Daily
Novartis' $23B U.S. Investment Boosts Pharma Manufacturing | Pharma and Biotech Daily
AstraZeneca's £300M UK Investment Resumes Amid FDA Pilot | Pharma and Biotech Daily
AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily
Sun Pharma's $11.75B Organon Deal: Industry Shockwave | Pharma and Biotech Daily
Merck Unveils PD-1xVEGF Data, Delays Phase 3 Plans | Pharma and Biotech Daily
Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily
Amneal's $1.1B Biosimilars Move & Merck's HIV Pill | Pharma and Biotech Daily
Merck Welireg Fails, Roche Enspryng Shines in Trials | Pharma and Biotech Daily
Eli Lilly's $7B Kelonia Buy Boosts CAR-T Tech | Pharma and Biotech Daily
Kailera IPO Raises $625M for Obesity Drug | Pharma and Biotech Daily
Gene Therapy Setbacks and Strategic Shifts in Biotech
AI Integration and Regulatory Shifts in Pharma
AI Integration, FDA Milestones, and Strategic Shifts: Navigating Pharma's Future
Radiopharmaceuticals to CAR-T: Pharma's Cutting-Edge Advances
Biopunk Revolution: Reshaping Biotech Innovation
Revolutionizing Pharma: Key Innovations and Strategic Shifts
Navigating Breakthroughs: Pharma's Evolution in Innovation and Strategy
FDA's New Agenda & Gilead's Oncology Leap
Pharma's Future: Mergers, Innovation, and AI
Navigating Biopharma's Strategic Shift: Key Developments
Immunotherapy Breakthroughs and Regulatory Shifts in Pharma
Oral GLP-1 Breakthroughs and Strategic Biotech Shifts
Pharma Giants Transforming Through Strategic Acquisitions and AI
Biogen's SMA Breakthrough and AI's Rise in Pharma
Breakthroughs in COPD, CAR-T, and Gene Therapy
Transformative FDA Approvals and Biotech Innovations
Strategic Shifts and Breakthroughs in Pharma Innovation
Pharma 2025: Innovation Amidst Legal and Market Shifts
Navigating Pharma's Future: Key Innovations and Regulatory Shifts
Breakthroughs in Obesity and Oncology: Key Industry Shifts
Exploring Breakthroughs in Cell Therapy and Prostate Cancer
Revolutionizing Therapies: Psoriasis Breakthroughs and Biosimilar Expansion
AI Advances and Regulatory Shifts: Biopharma's New Frontier
Transformative Trials and Strategic Shifts in Pharma
Navigating Breakthroughs and Challenges in Pharma: RSV, HIV, and Neurotech
Orphan Drug Surge, FDA Streamlining, and AI Innovations
Breakthroughs and Strategic Shifts in Pharma 2023
Revolutionizing Pharma: mRNA Innovations and FDA Shifts
Navigating Regulatory Shifts and Clinical Breakthroughs in Pharma
Navigating Regulatory Shifts Amid Biotech Breakthroughs
Pharma Innovations: Employer Healthcare Shifts & Biotech Breakthroughs
Patent Settlements and Strategic Collaborations Transform Biotech
Pharma Innovations: AI, GLP-1 Breakthroughs, & Regulatory Hurdles
Transformative Breakthroughs and Challenges in Pharma
Rapid Approvals and Breakthroughs in Pharma Innovation
Oncology Breakthroughs and Regulatory Shifts Unveiled
Transformative Trends in Biopharma: Licensing, Approvals, and Partnerships
Obesity Breakthroughs, Rare Disease Approvals, and Ethical Milestones
Shaping the Future: Breakthroughs, Battles, and Biotech Trends
Regulatory Shifts and Scientific Breakthroughs Reshape Pharma
Breakthroughs and Challenges in Pharma Innovation
Pharma Innovations: Regulatory Shifts and Breakthroughs
Revolutionizing Therapies: Autoimmune Advances and Oncological Expansions
Navigating FDA Shifts: Innovations and Regulatory Challenges
Navigating Regulatory Shifts and Industry Innovations
Navigating Shifts: Leadership, Regulatory, and Breakthroughs in Pharma
RNA Therapies and mRNA Challenges: Industry Shifts
Pharma 2026: Strategic Shifts and Regulatory Challenges
Biotech Breakthroughs: AI, CAR-T, and Clinical Trials
Biogen's Spinraza Revamp and FDA's IP Crackdown
Transformative Shifts: Rare Diseases, IPOs, and GLP-1 Innovations
Biotech Breakthroughs: Lupus Therapy and GLP-1 Rivalry
Navigating Biotech Breakthroughs: Regulatory Shifts and Strategic Moves
Transformative Trends in Pharma and Biotech Developments
Strategic Shifts and Breakthroughs in Pharma 2026